Ligand (Promacta assets) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Ligand (Promacta assets) General Information

Description

Portfolio of assets.The asset includes the royalty stream on worldwide net sales of Promacta.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • San Diego, CA
  • United States
Primary Industry
Buildings and Property
Acquirer
Royalty Pharma
Corporate Office
  • San Diego, CA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ligand (Promacta assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ligand (Promacta assets)‘s full profile, request access.

Request a free trial

Ligand (Promacta assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ligand (Promacta assets)‘s full profile, request access.

Request a free trial

Ligand (Promacta assets) FAQs

  • Where is Ligand (Promacta assets) headquartered?

    Ligand (Promacta assets) is headquartered in San Diego, CA.

  • What industry is Ligand (Promacta assets) in?

    Ligand (Promacta assets)’s primary industry is Buildings and Property.

  • Is Ligand (Promacta assets) a private or public company?

    Ligand (Promacta assets) is a Private company.

  • What is the current valuation of Ligand (Promacta assets)?

    The current valuation of Ligand (Promacta assets) is .

  • What is Ligand (Promacta assets)’s current revenue?

    The current revenue for Ligand (Promacta assets) is .

  • Who are Ligand (Promacta assets)’s investors?

    Ligand Pharmaceuticals has invested in Ligand (Promacta assets).

  • When was Ligand (Promacta assets) acquired?

    Ligand (Promacta assets) was acquired on 06-Mar-2019.

  • Who acquired Ligand (Promacta assets)?

    Ligand (Promacta assets) was acquired by Royalty Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »